• Comment (1)

Experimental Pill May Ease Multiple Sclerosis Disability

Latest trial shows laquinimod can also help prevent relapse

March 14, 2012 RSS Feed Print

But, Coetzee added, "This study illustrates that there are oral agents becoming available for people with MS. And, it brings hope that we will have a next generation of agents, and that we can hopefully stop the progression of MS."

More information

Learn more about multiple sclerosis from the National Multiple Sclerosis Society.

Copyright © 2012 HealthDay. All rights reserved.

Tags:
clinical trials,
therapy,
research,
diseases,
prescription drugs

Reader Comments Read all comments (1)

Add Your Thoughts
Your comment will be posted immediately, unless it is spam or contains profanity. For more information, please see our Comments FAQ.

Eat + Run

advertisement

rounded corners

Slideshows »
Unusual Uses for Greek Yogurt

advertisement